VSTM1-v2 does not drive human Th17 cell differentiation: A replication study

Helen J. von Richthofen; Florianne M.J. Hafkamp; Anouk van Haperen; Esther C. de Jong; Linde Meyaard

doi:10.1371/journal.pone.0284404

VSTM1-v2 does not drive human Th17 cell differentiation: A replication study

Helen J. von Richthofen
, Florianne M.J. Hafkamp
, Anouk van Haperen
, Esther C. de Jong
, Linde Meyaard^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

5 Downloads (Pure)

Abstract

Signal inhibitory receptor on leukocytes-1 (SIRL-1) is an immune inhibitory receptor expressed on human myeloid cells. We previously showed that dendritic cell (DC)-driven Th17 cell differentiation of human naive CD4+ T cells requires presence of neutrophils, which is inhibited by SIRL-1 ligation. VSTM1-v2 is a soluble isoform of SIRL-1, which was previously proposed to function as a Th17 polarizing cytokine. Here, we investigated the effect of VSTM1-v2 on DC-driven Th17 cell development. Neutrophils induced DC-driven Th17 cell differentiation, which was not enhanced by VSTM1-v2. Similarly, we found no effect of VSTM1-v2 on cytokine-driven Th17 cell development. Thus, our results do not support a role for VSTM1-v2 in Th17 cell differentiation.

Original language	English
Article number	e0284404
Journal	PLoS ONE
Volume	18
Issue number	4
DOIs	https://doi.org/10.1371/journal.pone.0284404
Publication status	Published - Apr 2023

Access to Document

10.1371/journal.pone.0284404Licence: CC BY

journal.pone.0284404Final published version, 789 KBLicence: CC BY

Cite this

@article{29d97415a32742758bac5f44a35ebbe4,

title = "VSTM1-v2 does not drive human Th17 cell differentiation: A replication study",

abstract = "Signal inhibitory receptor on leukocytes-1 (SIRL-1) is an immune inhibitory receptor expressed on human myeloid cells. We previously showed that dendritic cell (DC)-driven Th17 cell differentiation of human naive CD4+ T cells requires presence of neutrophils, which is inhibited by SIRL-1 ligation. VSTM1-v2 is a soluble isoform of SIRL-1, which was previously proposed to function as a Th17 polarizing cytokine. Here, we investigated the effect of VSTM1-v2 on DC-driven Th17 cell development. Neutrophils induced DC-driven Th17 cell differentiation, which was not enhanced by VSTM1-v2. Similarly, we found no effect of VSTM1-v2 on cytokine-driven Th17 cell development. Thus, our results do not support a role for VSTM1-v2 in Th17 cell differentiation.",

author = "\{von Richthofen\}, \{Helen J.\} and Hafkamp, \{Florianne M.J.\} and \{van Haperen\}, Anouk and \{de Jong\}, \{Esther C.\} and Linde Meyaard",

note = "Publisher Copyright: {\textcopyright} 2023 von Richthofen et al.",

year = "2023",

month = apr,

doi = "10.1371/journal.pone.0284404",

language = "English",

volume = "18",

journal = "PLoS ONE",

issn = "1932-6203",

publisher = "Public Library of Science",

number = "4",

}

TY - JOUR

T1 - VSTM1-v2 does not drive human Th17 cell differentiation

T2 - A replication study

AU - von Richthofen, Helen J.

AU - Hafkamp, Florianne M.J.

AU - van Haperen, Anouk

AU - de Jong, Esther C.

AU - Meyaard, Linde

PY - 2023/4

Y1 - 2023/4

N2 - Signal inhibitory receptor on leukocytes-1 (SIRL-1) is an immune inhibitory receptor expressed on human myeloid cells. We previously showed that dendritic cell (DC)-driven Th17 cell differentiation of human naive CD4+ T cells requires presence of neutrophils, which is inhibited by SIRL-1 ligation. VSTM1-v2 is a soluble isoform of SIRL-1, which was previously proposed to function as a Th17 polarizing cytokine. Here, we investigated the effect of VSTM1-v2 on DC-driven Th17 cell development. Neutrophils induced DC-driven Th17 cell differentiation, which was not enhanced by VSTM1-v2. Similarly, we found no effect of VSTM1-v2 on cytokine-driven Th17 cell development. Thus, our results do not support a role for VSTM1-v2 in Th17 cell differentiation.

AB - Signal inhibitory receptor on leukocytes-1 (SIRL-1) is an immune inhibitory receptor expressed on human myeloid cells. We previously showed that dendritic cell (DC)-driven Th17 cell differentiation of human naive CD4+ T cells requires presence of neutrophils, which is inhibited by SIRL-1 ligation. VSTM1-v2 is a soluble isoform of SIRL-1, which was previously proposed to function as a Th17 polarizing cytokine. Here, we investigated the effect of VSTM1-v2 on DC-driven Th17 cell development. Neutrophils induced DC-driven Th17 cell differentiation, which was not enhanced by VSTM1-v2. Similarly, we found no effect of VSTM1-v2 on cytokine-driven Th17 cell development. Thus, our results do not support a role for VSTM1-v2 in Th17 cell differentiation.

UR - https://www.scopus.com/pages/publications/85152594528

U2 - 10.1371/journal.pone.0284404

DO - 10.1371/journal.pone.0284404

M3 - Article

C2 - 37053248

AN - SCOPUS:85152594528

SN - 1932-6203

VL - 18

JO - PLoS ONE

JF - PLoS ONE

IS - 4

M1 - e0284404

ER -

VSTM1-v2 does not drive human Th17 cell differentiation: A replication study

Abstract

Access to Document

Other files and links

Fingerprint

Cite this